OpenURL Connection Search

Select item for more details and to access through your institution.

Central nervous system prophylaxis with intrathecal liposomal cytarabine in a subset of high-risk patients with diffuse large B-cell lymphoma receiving first line systemic therapy in a prospective trial.
Published in:
2016
By:
- González-Barca, E.;
- Canales, M.;
- Salar, A.;
- Ferreiro-Martínez, J.;
- Ferrer-Bordes, S.;
- García-Marco, J.;
- Sánchez-Blanco, J.;
- García-Frade, J.;
- Peñalver, J.;
- Bello-López, J.;
- Sancho, J.;
- Caballero, D.;
- González-Barca, E;
- Ferreiro-Martínez, J J;
- García-Marco, J A;
- Sánchez-Blanco, J J;
- García-Frade, J;
- Peñalver, J;
- Bello-López, J L;
- Sancho, J M
Publication type:
journal article
Predisposing Factors and Outcome of Staphylococcus aureus Bacteremia in Neutropenic Patients with Cancer.
Published in:
European Journal of Clinical Microbiology & Infectious Diseases, 2001, v. 20, n. 2, p. 117
By:
- González-Barca, E.;
- Carratalà, J.;
- Mykietiuk, A.;
- Fernández-Sevilla, A.;
- Gudiol, F.
Publication type:
Article
All-trans retinoic acid-induced myositis in a case of acute promyelocytic leukaemia.
Published in:
2008
By:
- Oliveira AC;
- Domingo-Domenech E;
- Arnan M;
- Gallardo D;
- Puig I;
- González-Barca E
Publication type:
Journal Article
All-trans retinoic acid-induced myositis in a case of acute promyelocytic leukaemia.
Published in:
2008
By:
- Oliveira, A. C.;
- Domingo-Domenech, E.;
- Arnan, M.;
- Gallardo, D.;
- Puig, I.;
- González-Barca, E.
Publication type:
Letter
Autologous stem cell transplantation (ASCT) with immunologically purged progenitor cells in patients with advanced stage follicular lymphoma after early partial or complete remission: toxicity, follow-up of minimal residual disease and survival.
Published in:
Bone Marrow Transplantation, 2000, v. 26, n. 10, p. 1051
By:
- González-Barca, E;
- Fernández de Sevilla, A;
- Domingo-Claros, A;
- Romagosa, V;
- Martín-Henao, G A;
- De Sanjose, S;
- Carmona, M;
- Petit, J;
- García, J;
- Grañena, A
Publication type:
Article
Autologous stem cell transplantation (ASCT) with immunologically purged progenitor cells in patients with advanced stage follicular lymphoma after early partial or complete remission: toxicity, follow-up of minimal residual disease and survival.
Published in:
Bone Marrow Transplantation, 2000, v. 26, n. 9, p. 1051, doi. 10.1038/sj.bmt.1702660
By:
- González-Barca, E;
- Fernández de Sevilla, A;
- Domingo-Claros, A;
- Romagosa, V;
- Martín-Henao, GA;
- De Sanjose, S;
- Carmona, M;
- Petit, J;
- García, J;
- Grañena, A
Publication type:
Article
Immunomagnetic bone marrow (BM) and peripheral blood progenitor cell (PBPC) purging in follicular lymphoma (FL).
Published in:
Bone Marrow Transplantation, 1999, v. 23, n. 6, p. 579, doi. 10.1038/sj.bmt.1701612
By:
- Martín-Henao, G A;
- Picón, M;
- Limón, A;
- Carmona, M;
- Amill, B;
- Azqueta, C;
- López, R;
- González-Barca, E;
- Grañena, A;
- Brunet, S;
- García, J
Publication type:
Article
Noninvasive mechanical ventilation in a patient with respiratory failure after hematopoietic progenitor transplantation.
Published in:
Bone Marrow Transplantation, 1998, v. 22, n. 11, p. 1123
By:
- Marín, D;
- González-Barca, E;
- Domingo, E;
- Berlanga, J;
- Grañena, A
Publication type:
Article
Umbilical cord blood transplantation from unrelated donors in an adult weighing 90 kilograms. Role of immunosuppression in engraftment.
Published in:
Bone Marrow Transplantation, 1997, v. 20, n. 4, p. 333
By:
- González-Barca, E;
- Querol, S;
- Grañena, A;
- Sarra, J;
- Sirchia, G;
- García, J
Publication type:
Article
Lenalidomide in combination with R‐ESHAP in patients with relapsed or refractory diffuse large B‐cell lymphoma: A phase 2 study from GELTAMO.
Published in:
British Journal of Haematology, 2023, v. 203, n. 2, p. 202, doi. 10.1111/bjh.18989
By:
- Martín García‐Sancho, A.;
- Baile, M.;
- Rodríguez, G.;
- Dlouhy, I.;
- Sancho, J. M.;
- Jarque, I.;
- González‐Barca, E.;
- Salar, A.;
- Espeso, M.;
- Grande, C.;
- Bergua, J.;
- Montes‐Moreno, S.;
- Redondo, A.;
- Enjuanes, A.;
- Campo, E.;
- López‐Guillermo, A.;
- Caballero, D.
Publication type:
Article
Posttransplant monomorphic Burkitt's lymphoma: clinical characteristics and outcome of a multicenter series.
Published in:
Annals of Hematology, 2018, v. 97, n. 12, p. 2417, doi. 10.1007/s00277-018-3473-8
By:
- on behalf of the Grupo Español de Linfomas/Trasplante Autólogo de Médula Ósea (GEL/TAMO cooperative group);
- Grupo Español de Linfomas/Trasplante Autólogo de Médula Ósea (GEL/TAMO cooperative group);
- Bobillo, S.;
- Abrisqueta, P.;
- Montoro, J.;
- López, A.;
- Bosch, F.;
- Bento, L.;
- Montes, S.;
- Sánchez-González, B.;
- Giné, E.;
- Romero, S.;
- Alcoceba, M.;
- González-Barca, E.;
- González de Villambrosía, S.;
- Sancho, J. M.;
- Gómez, P.
Publication type:
Article
Autologous stem cell transplantation (ASCT) in patients with mantle cell lymphoma: a retrospective study of the Spanish lymphoma group (GELTAMO).
Published in:
2017
By:
- García-Noblejas, A.;
- Cannata-Ortiz, J.;
- Conde, E.;
- González Barca, E.;
- Gutiérrez, N.;
- Rojas, R.;
- Vidal, M.J.;
- Ramírez, M.J.;
- Jiménez-Ubieto, A.;
- García-Ruiz, J.C.;
- Sancho, J.;
- López, A.;
- Ríos Rull, P.;
- Novelli, S.;
- Albo, C.;
- Debén, G.;
- López-Guillermo, A.;
- Nicolás, C.;
- González de Villambrosia, S.;
- Mercadal, S.
Publication type:
journal article
Prospective study of prognostic factors in asymptomatic patients with B-cell chronic lymphocytic leukemia-like lymphocytosis: the cut-off of 11 x 10(9)/L monoclonal lymphocytes better identifies subgroups with different outcomes.
Published in:
2015
By:
- Oliveira, A C;
- Fernández de Sevilla, A;
- Domingo, A;
- De La Banda, E;
- Domingo-Domènech, E;
- Mercadal, S;
- Ruiz-Xivillé, N;
- Alonso, E;
- Encuentra, M;
- González-Barca, E
Publication type:
Journal Article
Prospective study of prognostic factors in asymptomatic patients with B-cell chronic lymphocytic leukemia-like lymphocytosis: the cut-off of 11 × 10/L monoclonal lymphocytes better identifies subgroups with different outcomes.
Published in:
Annals of Hematology, 2015, v. 94, n. 4, p. 627, doi. 10.1007/s00277-014-2263-1
By:
- Oliveira, A.;
- Fernández de Sevilla, A.;
- Domingo, A.;
- De La Banda, E.;
- Domingo-Domènech, E.;
- Mercadal, S.;
- Ruiz-Xivillé, N.;
- Alonso, E.;
- Encuentra, M.;
- González-Barca, E.
Publication type:
Article
Low-dose subcutaneous interleukin-2 in patients with minimal residual lymphoid neoplasm disease.
Published in:
European Journal of Haematology, 1999, v. 62, n. 4, p. 231, doi. 10.1111/j.1600-0609.1999.tb01752.x
By:
- González-Barca, E.;
- Grañena, A.;
- Fernández-Sevilla, A.;
- Moreno, V.;
- Salar, A.;
- Rueda, F.;
- García, J.
Publication type:
Article
Diffuse large B-cell lymphoma: is morphologic subdivision useful in clinical management?
Published in:
European Journal of Haematology, 1998, v. 60, n. 3, p. 202, doi. 10.1111/j.1600-0609.1998.tb01023.x
By:
- Salar, A.;
- Sevilla, A. Fernández;
- Romagosa, V.;
- Domingo-Claros, A.;
- González-Barca, E.;
- Pera, J.;
- Climent, J.;
- Grañena, A.
Publication type:
Article
Distribution and incidence rates of lymphoid neoplasms according to the REAL classification in a single institution. A prospective study of 940 cases.
Published in:
European Journal of Haematology, 1997, v. 59, n. 4, p. 231, doi. 10.1111/j.1600-0609.1997.tb00982.x
By:
- Salar, A.;
- Sevilla, A. Fernández;
- Romagosa, V.;
- Domingo-Claros, A.;
- González-Barca, E.;
- Sanjosé, S.;
- Pera, J.;
- Servitje, O.;
- Grañena, A.
Publication type:
Article
FACTORS INFLUENCING SURVIVAL AND PROLONGED VIRAL REPLICATION IN PATIENTS WITH LYMPHOMA AND COVID‐19: AN OBSERVATIONAL COHORT STUDY FROM GELTAMO SPANISH GROUP.
Published in:
Hematological Oncology, 2023, v. 41, p. 816, doi. 10.1002/hon.3165_665
By:
- Cabero‐Martínez, A.;
- Bastos‐Oreiro, M.;
- López‐García, A.;
- Baile, M.;
- Franch, M.;
- Llacer‐Ferrandis, M. J.;
- Izuzquiza, M.;
- Jiménez‐Ubieto, A.;
- Escoda, L.;
- Nistal, S.;
- González‐Barca, E.;
- García‐Belmonte, D.;
- Hernández‐Mohedo, F.;
- Sánchez‐González, B.;
- Martin‐Martitegui, X.;
- Arguiñano, J. M.;
- Ramirez‐Payer, A.;
- Roldan‐Perez, A.;
- Zeberio, I.;
- Diaz‐Galvez, J.
Publication type:
Article
EFFICACY AND SAFETY OF IBRUTINIB IN COMBINATION WITH RITUXIMAB AS FRONTLINE TREATMENT FOR INDOLENT CLINICAL FORMS OF MANTLE CELL LYMPHOMA. RESULTS OF THE GELTAMO IMCL‐2015 STUDY.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.60_2879
By:
- Giné, E.;
- De la Cruz, F.;
- Ubieto, A. Jiménez;
- Jiménez, J. López;
- García‐Sancho, A. Martín;
- Terol, M. J.;
- González‐Barca, E.;
- Casanova, M.;
- De la Fuente Burguera, A.;
- Niebla, A. Marín;
- Prat, A. Muntanola;
- González‐López, T. J.;
- Aymerich, M.;
- Setoain, X.;
- Cortés‐Romera, M.;
- Rotger, A.;
- Medina, A.;
- García‐Sanz, R.;
- Campo, E.;
- López‐Guillermo, A.
Publication type:
Article
IBRUTINIB FOLLOWED BY OFATUMUMAB CONSOLIDATION IN PREVIOUSLY UNTREATED PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): GELLC‐7 TRIAL FROM THE SPANISH GROUP OF CLL (GELLC)
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.47_2880
By:
- Abrisqueta, P.;
- González‐Barca, E.;
- Ferrà, C.;
- Ríos, E.;
- Fernández de la Mata, M.;
- Delgado, J.;
- Andreu, R.;
- Án. Hernández‐Rivas, J.;
- José Terol, M.;
- González, M.;
- Belén Vidriales, M.;
- Baltasar, P.;
- De la Serna, J.;
- Ramírez Páyer, Án.;
- Ballester, C.;
- Moreno, C.;
- García‐Marco, J. A.;
- Córdoba, R.;
- Yáñez, L.;
- Casado, L. F.
Publication type:
Article
INTRAVENOUS HIGH DOSE METHOTREXATE AS CENTRAL NERVOUS SYSTEM (CNS) PROPHYLAXIS IN PATIENTS WITH DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) WITH HIGH RISK FOR CNS PROGRESSION.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.46_2881
By:
- Villarreal, J. A.;
- Rovira, J.;
- Franch, M.;
- Encuentra, M.;
- Blazevic, D.;
- Rodriguez, M.;
- Kelleger, N.;
- Martín, S.;
- Oliveira, A. C.;
- Domingo Domenech, E.;
- Ribera, J. M.;
- Sureda, A.;
- Sancho, J. M.;
- Escoda, L.;
- González‐Barca, E.
Publication type:
Article
R‐GDP SCHEDULE IN PATIENTS WITH REFRACTORY OR RELAPSED B‐CELL NON‐HODGKIN LYMPHOMA (B‐NHL)
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.42_2881
By:
- Rovira, J;
- González‐Barca, E;
- M. Sancho, J;
- Kelleher, N;
- Rodríguez, M;
- Fox, L;
- Parody, R;
- Martin, S;
- Vicent, A;
- Villarroel, J;
- de la Fuente, C;
- Ribera, J. M;
- Sureda, A;
- Escoda, L
Publication type:
Article
LONG‐TERM ANALYSES FROM L‐MIND, A PHASE II STUDY OF TAFASITAMAB PLUS LENALIDOMIDE (LEN) IN PATIENTS (PTS) WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA (R/R DLBCL)
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.28_2879
By:
- Duell, J;
- Maddocks, K. J;
- González‐Barca, E;
- Jurczak, W;
- Liberati, A. M;
- Obr, A;
- Gaidano, G;
- Abrisqueta, P;
- André, M;
- Dreyling, M;
- Menne, T;
- Dirnberger‐Hertweck, M.;
- Weirather, J;
- Ambarkhane, S;
- Salles, G
Publication type:
Article
CHARACTERIZATION OF THE ONCOGENIC PHENOTYPE IN EXTRANODAL NATURAL KILLER/T‐CELL LYMPHOMA, NASAL TYPE THROUGH GENE EXPRESSION PROFILE. SPANISH LYMPHOMA GROUP GELTAMO.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.139_2880
By:
- González-Barca, E;
- Gato, L;
- Esteve, A;
- Sanz‐Pamplona, R;
- Tomás, L;
- Rodriguez, M;
- Martín García‐Sancho, A;
- Córdoba, R;
- Monter, A;
- Bastos, M;
- Bergua Burgues, J. M;
- Sayas, M. J;
- Viguria Alegria, M. C;
- Sánchez Blanco, J. J;
- Roig, M;
- Luzardo Henriquez, H. D;
- Oña, R;
- Cabezudo, E;
- Infante, M. S;
- Queizan, J. A
Publication type:
Article
BET INHIBITOR RG6146, VENETOCLAX, AND RITUXIMAB IS A HIGHLY ACTIVE REGIMEN IN RELAPSED/REFRACTORY (R/R) DLBCL: INITIAL REPORT OF PHASE 1B SAFETY, BIOMARKER, AND RESPONSE DATA.
Published in:
Hematological Oncology, 2019, v. 37, p. 174, doi. 10.1002/hon.131_2629
By:
- Dickinson, M.;
- Briones Mejjide, J.;
- Herrera, A.F.;
- González Barca, E.;
- Ghosh, N.;
- Cordoba, R.;
- Rutherford, S.C.;
- Advani, R.;
- Bournazou, E.;
- Labriola‐Tompkins, E.;
- Friess, T.;
- Chesne, E.;
- Brouwer‐Visser, J.;
- Lechner, K.;
- Brennan, B.;
- Nueesch, E.;
- De Mario, M.;
- Hutchings, M.
Publication type:
Article
PRIMARY ANALYSIS RESULTS OF THE SINGLE‐ARM PHASE II STUDY OF MOR208 PLUS LENALIDOMIDE IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA (L‐MIND).
Published in:
Hematological Oncology, 2019, v. 37, p. 173, doi. 10.1002/hon.130_2629
By:
- Salles, G.;
- Duell, J.;
- González Barca, E.;
- Jurczak, W.;
- Liberati, A.M.;
- Nagy, Z.;
- Obr, A.;
- Gaidano, G.;
- Andre, M.;
- Kalakonda, N.;
- Dreyling, M.;
- Zinzani, P.L.;
- Dirnberger‐Hertweck, M.;
- Weirather, J.;
- Ambarkhane, S.;
- Maddocks, K.
Publication type:
Article
BET INHIBITOR RG6146, VENETOCLAX, AND RITUXIMAB IS A HIGHLY ACTIVE REGIMEN IN RELAPSED/REFRACTORY (R/R) DLBCL: INITIAL REPORT OF PHASE 1B SAFETY, BIOMARKER, AND RESPONSE DATA.
Published in:
Hematological Oncology, 2019, v. 37, p. 174, doi. 10.1002/hon.131_2629
By:
- Dickinson, M.;
- Briones Mejjide, J.;
- Herrera, A.F.;
- González Barca, E.;
- Ghosh, N.;
- Cordoba, R.;
- Rutherford, S.C.;
- Advani, R.;
- Bournazou, E.;
- Labriola‐Tompkins, E.;
- Friess, T.;
- Chesne, E.;
- Brouwer‐Visser, J.;
- Lechner, K.;
- Brennan, B.;
- Nueesch, E.;
- De Mario, M.;
- Hutchings, M.
Publication type:
Article
PRIMARY ANALYSIS RESULTS OF THE SINGLE‐ARM PHASE II STUDY OF MOR208 PLUS LENALIDOMIDE IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA (L‐MIND).
Published in:
Hematological Oncology, 2019, v. 37, p. 173, doi. 10.1002/hon.130_2629
By:
- Salles, G.;
- Duell, J.;
- González Barca, E.;
- Jurczak, W.;
- Liberati, A.M.;
- Nagy, Z.;
- Obr, A.;
- Gaidano, G.;
- Andre, M.;
- Kalakonda, N.;
- Dreyling, M.;
- Zinzani, P.L.;
- Dirnberger‐Hertweck, M.;
- Weirather, J.;
- Ambarkhane, S.;
- Maddocks, K.
Publication type:
Article
APPLICATION OF CELL-OF-ORIGIN SUBTYPES DETERMINED BY DIGITAL GENE EXPRESSION IN HIV-RELATED DIFFUSE LARGE B-CELL LYMPHOMAS.
Published in:
Hematological Oncology, 2017, v. 35, p. 156, doi. 10.1002/hon.2438_11
By:
- Baptista, M.;
- Tapia, G.;
- Muñoz ‐ Marmol, A.;
- Muncunill, J.;
- Montoto, S.;
- Gribben, J.;
- Calaminici, M.;
- Martinez, A.;
- Gonzalez ‐ Farre, B.;
- López ‐ Guillermo, A.;
- González ‐ Barca, E.;
- Terol, M.;
- Miralles, P.;
- Alcoceba, M.;
- Vall ‐ Llovera, F.;
- Briones, J.;
- Abrisqueta, P.;
- Abella, E.;
- Provencio, M.;
- García ‐ Ballesteros, C.
Publication type:
Article
Effective treatments are required for patients with diffuse large B-cell lymphoma ( DLBCL) with primary refractory disease.
Published in:
Hematological Oncology, 2017, v. 35, p. 344, doi. 10.1002/hon.2439_92
By:
- Salas, Q.Q.;
- Domingo Domenech, E.;
- Mercadal, S.;
- Oliveira, A.;
- Aguilera, C.;
- De la Banda, E.;
- Climent, F.;
- Lucas, A.;
- Garcia, N.;
- Baca, C.;
- Fernandez de Sevilla, A.;
- Sureda, A.;
- González Barca, E.
Publication type:
Article
Lenalidomide in combination with R-ESHAP in patients with relapsed or refractory diffuse large B-cell lymphoma: A phase 2 study from the Spanish group GELTAMO.
Published in:
Hematological Oncology, 2017, v. 35, p. 345, doi. 10.1002/hon.2439_93
By:
- Martín, A.;
- Baile, M.;
- Rodríguez, G.;
- Dlouhy, I.;
- Sancho, J.M.;
- Jarque, I.;
- González ‐ Barca, E.;
- Salar, A.;
- Espeso, M.;
- Grande, C.;
- Bergua, J.;
- Montes ‐ Moreno, S.;
- López ‐ Guillermo, A.;
- Campo, E.;
- Caballero, D.
Publication type:
Article
Post-transplant monomorphic Burkitt's lymphoma: Clinical characteristics and outcome of a multicenter series.
Published in:
Hematological Oncology, 2017, v. 35, p. 349, doi. 10.1002/hon.2439_100
By:
- Bobillo, S.;
- Abrisqueta, P.;
- Sánchez ‐ González, B.;
- Giné, E.;
- Romero, S.;
- Alcoceba, M.;
- González ‐ Barca, E.;
- González de Villambrosía, S.;
- Sancho, J.M.;
- Castellví, J.;
- López, A.;
- Bosch, F.
Publication type:
Article
CD30 expression in diffuse large B-cell lymphoma correlates with non- GCB subtype but does not have prognostic impact in patients treated with first line R-CHOP/ R-CHOP-like.
Published in:
Hematological Oncology, 2017, v. 35, p. 290, doi. 10.1002/hon.2439_19
By:
- Salas, Q.;
- Climent, F.;
- Tapia, G.;
- Riasol, M.;
- Mercadal, S.;
- Domingo Domenech, E.;
- Oliveira, A.;
- Moreno ‐ Velázquez, M.;
- Garcia, O.;
- Aguilera, C.;
- Fernandez de Sevilla, A.;
- Sureda, A.;
- Sancho, J.;
- González Barca, E.
Publication type:
Article
L-MIND: MOR208 COMBINED WITH LENALIDOMIDE (LEN) IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA (R-R DLBCL) - A SINGLE-ARM PHASE II STUDY.
Published in:
Hematological Oncology, 2017, v. 35, p. 51, doi. 10.1002/hon.2437_35
By:
- Salles, G.;
- González Barca, E.;
- Jurczak, W.;
- Liberati, A.M.;
- Duell, J.;
- Nagy, Z.;
- Papajík, T.;
- Andre, M.;
- Kalakonda, N.;
- Dreyling, M.;
- Zinzani, P.L.;
- Ambarkhane, S.;
- Weirather, J.;
- Maddocks, K.
Publication type:
Article
R-COMP VS R-CHOP AS FIRST-LINE THERAPY FOR DIFFUSE LARGE B-CELL LYMPHOMA IN PATIENTS OLDER THAN 60 YEARS: RESULTS FROM A RANDOMIZED PHASE 2 STUDY FROM THE SPANISH GELTAMO GROUP.
Published in:
Hematological Oncology, 2017, v. 35, p. 186, doi. 10.1002/hon.2438_47
By:
- Sancho, J.;
- Gual, F.;
- Fernández ‐ Álvarez, R.;
- González ‐ García, E.;
- Grande, C.;
- Gutiérrez, N.;
- Peñarrubia, M.;
- Batlle ‐ López, A.;
- González ‐ Barca, E.;
- Guinea, J.;
- Gimeno, E.;
- Peñalver, F.;
- Fuertes, M.;
- Gayoso, J.;
- Hernández ‐ Rivas, J.;
- Moraleda, J.;
- García, O.;
- Martín, A.
Publication type:
Article

Found: 35